JAK Inhibitor

4 clinical trials · Condition

Record	Firm	Date
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (NCT05090410)	Atsushi Kawakami	2021-03-03
Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (NCT05121298)	Atsushi Kawakami	2021-01-12

Every clearance here is in the API, with alerts when new ones post.